Pathobiology of CPB
Placing patients on CPB elicits a rapid and profound inflammatory
response. This response is highly complex and involves several interactive cellular
and humoral pathways. The inflammatory response to CPB is not mechanistically dissimilar
to that occurring after infection. Indeed, the spectrum and implications of the
CPB-induced inflammatory response are similar to those observed in the infectious
setting. The spectrum of this inflammatory response ranges from development of the
less severe systemic inflammatory response syndrome (SIRS) to severe multiorgan dysfunction
syndrome (MODS) ( Table 50-13
).
[211]
Although SIRS represents the less severe
end
of the inflammatory response spectrum and is usually associated with short-term survival,
it may be associated with or lead to a long-term increase in morbidity and mortality
if the paradigm that is known to exist for sepsis[212]
also applies to patients undergoing cardiac surgery with CPB ( Fig.
50-34
). In the clinical setting, a clear distinction between the host
inflammatory response to CPB and that to sepsis is frequently not justified. Several
host (e.g., diabetes), environmental (e.g., nosocomial infections), and intraoperative
(e.g., gut translocation) factors, as well as CPB itself, may predispose the patient
to infection.
A detailed description of the mechanisms underlying perioperative
injury in cardiac surgery patients is beyond the scope of this chapter. The interested
reader is referred to an extensive and exhaustive review by Laffey and colleagues
[213]
and to work by Gravlee and associates.[214]
Although several preoperative factors and patient-related conditions (e.g., active
ischemia, impaired ventricular function, diabetes) may modulate the host inflammatory
response, CPB itself evokes a profound multifaceted,
TABLE 50-13 -- Criteria for diagnosis of SIRS, sepsis, and MODS
SIRS: Diagnosis requires the
presence of two or more of the following: |
Temperature >38°C or <36°C |
Heart rate >90 beats/min |
Respiratory rate >20 breaths/min or PaCO2
<32 mm Hg |
Leukocytes >12,000, <4,000/mm3
,
or >10% immature (band) forms |
Sepsis: SIRS with documented
infection |
Severe Sepsis: Sepsis associated
with organ dysfunction, hypoperfusion, or hypotension |
Septic Shock: Sepsis with hypotension
despite adequate resuscitation, along with the presence of perfusion abnormalities |
MODS: A state of altered organ
function in an acutely ill patient such that homeostasis cannot be maintained without
intervention |
MODS, multiple organ dysfunction syndrome; SIRS, systemic inflammatory
response syndrome. |
From Laffey JG, Boylan JF, Cheng DC: The systemic inflammatory
response to cardiac surgery: Implications for the anesthesiologist. Anesthesiology
97:215–252, 2002. |
complex inflammatory host response. CPB and the host inflammatory response to CPB
have clear, direct, and immediate implications but also indirectly alter outcome
in that they can modulate (usually adversely) the patient's ability to respond to
subsequent challenges such as infection. Hence, the term "multiple-hit syndrome"
implies that the derangements that ensue after CPB involve multiple initiating and
exacerbating events.
Several perioperative factors may initiate an inflammatory response,
including factors that are not necessarily
Figure 50-34
Schematic diagram of the sequence of events by which
cardiopulmonary bypass may lead to the development of systemic inflammatory response
syndrome (SIRS).
specific to cardiac surgery such as nonspecific surgical trauma and blood transfusion,
as well as the cardiac-specific factors of CPB and hypothermia. Importantly, the
notion that the inflammatory response to CPB is monotonic and always proinflammatory
is probably overly simplistic. Several pathways (e.g., the cytokine pathway) that
are activated by CPB have both proinflammatory and anti-inflammatory effects. A
compensatory anti-inflammatory response is teleologically predictable and may play
an important role in the subsequent development of infection and infectious complications
( Fig. 50-35
).
Mechanistically, the inflammatory response is mediated by multiple
interactive pathways. The specific outcome in any individual patient depends on
the pattern (magnitude, type, time-course) of the response and the interaction between
the multiple pathways. The protean nature of the response likely reflects multiple
variables, including underlying genetic polymorphism, differential preoperative health,
and intraoperative factors such as the duration of CPB. The potential salutary influence
of perioperative management (e.g., optimizing circulatory support, optimizing respiratory
support) on the inflammatory response and thus on the propensity for the development
of complications is probably important, although ideal studies that would definitively
prove this are almost impossible to conduct.
Figure 50-35
Schematic diagram of the balance between the beneficial
and adverse effects and the resultant clinical sequelae of the inflammatory response
after cardiac surgery. CPB, cardiopulmonary bypass; SIRS, systemic inflammatory
response syndrome.
The inflammatory response to CPB is initiated immediately when
the patient's blood is exposed to the CPB tubing and oxygenator. However, ischemia-reperfusion
injury during CPB (myocardial ischemia-reperfusion with aortic clamping and unclamping,
noncardiac ischemia-reperfusion if organ hypoperfusion occurs during CPB) also contributes
to the inflammatory response. The role of gut translocation as a contributor to
CPB-associated injury remains unresolved, with the better-conducted studies failing
to demonstrate an association between intramucosal pH and endotoxemia. Specific
pathways involved in the response to CPB include the following:
- Cellular immune activation with adhesion, margination, and translocation
of granulocytes and macrophage activation. This cellular immune response is central
to the inflammatory response associated with CPB.
- The complement pathway, specifically, the alternative pathway thereof.
- The cytokine system with both proinflammatory and anti-inflammatory cytokine
activation resulting in immune modulation.
- Coagulation and fibrinolytic system activation.
- Upregulation of inducible NOS.
- Activation of the oxidant-stress pathway resulting in the production of
ROS, including superoxide and hydroxyl radicals and peroxynitrite.
Strong theoretical as well as basic science experimental and clinical data support
the concept that several perioperative interventions may modulate the host inflammatory
response. Strong in vitro experimental data indicate that several commonly used
anesthetics, including propofol, fentanyl, and midazolam, modulate one or more of
the previously mentioned pathways underlying the inflammatory response to CPB. Supporting
clinical data are currently lacking, partly because this is an emerging area of research,
but also because it is very difficult to demonstrate the effect of an agent in a
clinical setting when multiple other variables also influence the specific end point
being measured. Data regarding the CPB circuit and the conduct of CPB are somewhat
less murky. Evidence suggests that pulsatile flow (if achievable), membrane oxygenators,
heparin-bonded circuits, and moderate hypothermia exert a more favorable influence
on the host pathways underlying the inflammatory response to CPB.